OSCC prognosis linked to annexin A2 levels
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Elevated serum levels of annexin A2 are associated with oral squamous cell carcinoma (OSCC) incidence and reduced survival of patients with OSCC.
Why this matters
- New biomarkers for OSCC may help improve patient care.
- Patients with OSCC had higher annexin A2 levels (27.1 ng/mL) than benign oral disease patients (15.9 ng/mL) and control patients (15.0 ng/mL; P<.01).
- Elevated annexin A2 was associated with OSCC development in multivariate analysis (OR, 1.97; P<.05).
- Serum annexin A2 levels had an AUC value of 0.80 for distinguishing OSCC from benign oral disease and an AUC value of 0.77 for distinguishing OSCC from controls.
- Elevated annexin A2 was associated with TNM stage, tumor differentiation, lymph node metastasis, and d...